{
    "id": 19186,
    "cites": 41,
    "cited_by": 3,
    "reference": [
        "Murray Aitken, Ernst R. Berndt, and David M. Cutler. Prescription drug spending trends in the united states: Looking beyond the turning point. Health A\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acairs, 28(1):w151\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009cw160, January /February 2009. doi: 10.1377/hltha\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00ac.28.1.w151. URL http://content.healthaffairs. org/content/28/1/w151.abstract.",
        "Joseph G. Altonji and Charles R. Pierret. Employer learning and statistical discrimination. The Quarterly Journal of Economics, 116(1):pp. 313\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c350, 2001. ISSN 00335533. URL http://www. jstor.org/stable/2696451.",
        "Steven K. Baker and Robert S. Rosenson. Muscle injury associated with lipid lowering drugs. In D.S. Basow, editor, UpToDate. 2012.",
        "J J Brugts, T Yetgin, S E Hoeks, A M Gotto, J Shepherd, R G J Westendorp, A J M de Craen, R H Knopp, H Nakamura, P Ridker, R van Domburg, and J W Deckers. The bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081ts of statins in people without established cardiovascular disease but with cardiovascular risk factors: metaanalysis of randomised controlled trials. BMJ, 338, 6 2009. doi: 10.1136/bmj.b2376.",
        "Randall D. Cebul, James Rebitzer, Lowell J. Taylor, and Mark Votruba. Unhealthy insurance markets: Search frictions and the cost and quality of health insurance. American Economic Review, 101(5):1842\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1871, 2011.",
        "Amitabh Chandra, Jonathan Gruber, and Robin McKnight. Patient cost-sharing and hospitalization o\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acsets in the elderly. American Economic Review, 100(1), 2010.",
        "Amitabh Chandra, Jonathan Gruber, and Robin McKnight. The impact of patient cost-sharing on the poor: Evidence from massachusetts. Working Paper 18023, National Bureau of Economic Research, April 2012. URL http://www.nber.org/papers/w18023.",
        "Michael Dickstein. Physician vs. patient incentives in prescription drug choice. Manuscript, 2012.",
        "Hanming Fang and Alessandro Gavazza. Dynamic ine\u00c3\u00af\u00c2\u00ac\u00c6\u0092ciencies in an employment-based healthinsurance system: Theory and evidence. American Economic Review, 101(1):30473077, 2011.",
        "Richard G. Frank and Richard J. Zeckhauser. Custom-made versus ready-to-wear treatments: Behavioral propensities in physicians choices. Journal of Health Economics, 26, 2007.",
        "Martin Gaynor, Jian Li, and William B. Vogt. Substitution, spending o\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acsets, and prescription drug bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081t design. Forum for Health Economics & Policy, 10(2):4, 2007. URL http://ideas. repec.org/a/bpj/fhecpo/v10y2007i2n4.html.",
        "Dana P. Goldman, Geo\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acrey F. Joyce, Jose J. Escarce, Jennifer E. Pace, Matthew D. Solomon, Marianne Laouri, Pamela B. Landsman, and Steven M. Teutsch. Pharmacy Bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081ts and the Use of Drugs by the Chronically Ill. JAMA, 291(19):2344\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2350, 2004.",
        "Dana P. Goldman, Geo\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acrey F. Joyce, and Yuhui Zheng. Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health. JAMA, 298(1):61\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c69, 2007. doi: 10.1001/jama.298.1.61.",
        "Fusun F. Gonul, Franklin Carter, Elina Petrova, and Kannan Srinivasa. Physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 prescribing responses to a restricted formulary: the impact of medicaid preferred drug lists in illinois and louisiana. American Journal of Managed Care, 2005. Jorge Gonzalez, Catarina Sismeiro, Shantanu Dutta, and Philip Stern. Can branded drugs bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081t from generic entry? the role of detailing and price in switching to non-bioequivalent molecules.",
        "Good Stewardship Working Group. The top 5 lists in primary care: Meeting the responsibility of professionalism. Archives of Internal Medicine, 171(15):1385\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1390, 2011. doi: 10.1001/ archinternmed.2011.231. URL +http://dx.doi.org/10.1001/archinternmed.2011.231.",
        "Scott Grundy, James Cleeman, C. Noel Bairey Merz, H. Bryan Jr. Brewer, Luther Clark, Donald Hunninghake, Richard C. Pasternak, Sidney C. Jr Smith, and Neil Stone. Implications of recent clinical trials for the national cholesterol education program adult treatment panel iii guidelines. Circulation, 2004. For the Coordinating Committee of the National Cholesterol Education Program, Endorsed by the National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, and American Heart Association.",
        "Elizabeth Hargrave, Jack Hoadley, Laura Summer, and Katie Merrell. Medicare part d formularies, 2006-2010: A chartbook. Technical report, MedPac, October 2010. URL http://www.medpac. gov/documents/Oct10_PartDFormulariesChartBook_CONTRACTOR_RS.pdf.",
        "Judith K. Hellerstein. The importance of the physician in the generic versus trade-name prescription decision. RAND Journal of Economics, 29(1):108\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c136, Spring 1998. URL http://ideas.repec. org/a/rje/randje/v29y1998ispringp108-136.html.",
        "Bradley Herring. Supoptimal provision of preventive healthcare due to expected enrollee turnover among private insurers. Health Economics, 19:438\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c448, 2010.",
        "JH Hibbard and PJ Cunningham. How engaged are consumers in their health and health care, and why does it matter. Technical Report 8, Center for Studying Health System Change, 2008. URL http://www.hschange.com/CONTENT/1019/.",
        "Peter J. Huckfeldt and Christopher R. Knittel. Pharmaceutical use following generic entry: Paying less and buying less. Working Paper 17046, National Bureau of Economic Research, May 2011. URL http://www.nber.org/papers/w17046. Toshiaki Iizuka. Experts\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 agency problems: evidence from the prescription drug market in Japan.",
        "Toshiaki Iizuka. Physician agency and adoption of generic pharmaceuticals. American Economic Review, 102(6):2826\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2858, 2012.",
        "Tisha R. Joy and Robert A. Hegele. Narrative review: Statin-related myopathy. Annals of Internal Medicine, 150(12):858\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c868, 2009. doi: 10.7326/0003-4819-150-12-200906160-00009. URL +http: //dx.doi.org/10.7326/0003-4819-150-12-200906160-00009.",
        "Geo\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acrey F. Joyce, Mariana P. Carrera, Dana P. Goldman, and Neeraj Sood. Physician prescribing behavior and its impact on patient-level outcomes. American Journal of Managed Care, 17:e462\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009ce471, 2011. URL http://www.ajmc.com/articles/ Physician-Prescribing-Behavior-and-Its-Impact-on-Patient-Level-Outcomes.",
        "Kaiser Family Foundation. Employer health bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081ts: 2007 summary of \u00c3\u00af\u00c2\u00ac\u00c2\u0081ndings. Technical report, The Kaiser Family Foundation and Health Research & Educational Trust, October 2007.",
        "Kaiser Family Foundation. Employer health bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081ts: 2010 summary of \u00c3\u00af\u00c2\u00ac\u00c2\u0081ndings. Technical report, The Kaiser Family Foundation and Health Research & Educational Trust, October 2010.",
        "S Khan, R Sylvester, D Scott, and B. Pitts. Physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two midwestern states. Journal of Managed Care Pharmacy, 14(8):780\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c789, 2008.",
        "Joshua N. Liberman, David S. Hutchins, Richard G. Popiel, Mihir H. Patel, Saira A. Jan, and Jan E. Berger. Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy. The American Journal of Pharmacy Bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081ts, 2(2), 2010.",
        "Frank Limbrock. Pecuniary and non-pecuniary incentives in prescription pharmaceuticals: The case of statins. The B.E. Journal of Economic Analysis & Policy, 11(2), 2011.",
        "Douglas Lundin. Moral hazard in physician prescription behavior. Journal of Health Economics, 19(5), 2000.",
        "NEHI. Thinking outside the pillbox: A system-wide approach to improving patient medication adherence for chronic disease. Technical report, New England Healthcare Institute, 2009. URL http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_ approach_to_improving_patient_medication_adherence_for_chronic_disease.",
        "Robert S. Rosenson. Statins: Actions, side e\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acects, and administration. In D.S. Basow, editor, UpToDate. 2012.",
        "Fiona Scott Morton and Margaret Kyle. Markets for pharmaceutical products. In M.V. Pauly, T.G. McGuire, and P.P. Barros, editors, Handbook of Health Economics, number v. 2 in Handbook of Health Economics. Elsevier Science, 2011. ISBN 9780444535931. URL http://books.google. com/books?id=Pia95cLN84cC.",
        "William Shrank, Henry Young, Susan Ettner, Peter Glassman, Stephen Asch, and Richard Kravitz. Do the incentives in 3-tier pharmaceutical bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081t plans operate as intended? results from a physician leadership survey. American Journal of Managed Care, 11:16\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c22, 2005.",
        "William Shrank, Sarah Fox, Adele Kirk, Susan Ettner, Clairessa Cantrell, Peter Glassman, and Stephen Asch. The e\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acect of pharmacy bene\u00c3\u00af\u00c2\u00ac\u00c2\u0081t design on patient-physician communication about costs. Journal of General Internal Medicine, 21(4):334\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c339, 2006.",
        "Ross J. Jr Simpson. Challenges for Improving Medication Adherence. JAMA, 2006.",
        "ME Beth Smith, Nancy J Lee, Elizabeth Haney, and Susan Carson. Drug class review: Hmg-coa reductase inhibitors (statins) and \u00c3\u00af\u00c2\u00ac\u00c2\u0081xed-dose combination products containing a statin: Final report update 5. Technical report, Oregon Health & Science University, 2009. URL http: //www.ohsu.edu/drugeffectiveness/reports/final.cfm.",
        "Robyn Tamblyn, Rejean Laprise, James A. Hanley, Michael Abrahamowicz, Susan Scott, Nancy Mayo, Jerry Hurley, Roland Grad, Eric Latimer, Robert Perreault, Peter McLeod, Allen Huang, Pierre Larochelle, and Louise Mallet. Adverse Events Associated With Prescription Drug CostSharing Among Poor and Elderly Persons. JAMA, 285(4):421\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c429, 2001. doi: 10.1001/jama.285. 4.421.",
        "Anna A. Levine Taub, Anton Kolotilin, Robert S. Gibbons, and Ernst R. Berndt. The diversity of concentrated prescribing behavior: An application to antipsychotics. Working Paper 16823, National Bureau of Economic Research, February 2011. URL http://www.nber.org/papers/ w16823.",
        "Sriram Venkataraman and Stefan Stremersch. The debate on in\u00c3\u00af\u00c2\u00ac\u00e2\u0080\u009auencing doctors\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 decisions: Are drug characteristics the missing link? ERIM Report Series Reference No. ERS-2007-056-MKT., 2007, 09.",
        "S Virabhak and JA Shinogle. Physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 prescribing responses to a restricted formulary: the impact of medicaid preferred drug lists in illinois and louisiana. American Journal of Managed Care, 2005."
    ]
}